View source for SingleFraction versus Multifraction Stereotactic Ablative System Radiotherapy for Lung Oligometastases SAFRON Two Your Trans Tasman Light Oncology Group Thirteen10 Phase Two Randomized Clinical Trial

From EECH Central
Jump to: navigation, search

You do not have permission to edit this page, for the following reasons:

  • The action you have requested is limited to users in the group: Users.
  • You must confirm your email address before editing pages. Please set and validate your email address through your user preferences.

You can view and copy the source of this page.

Return to SingleFraction versus Multifraction Stereotactic Ablative System Radiotherapy for Lung Oligometastases SAFRON Two Your Trans Tasman Light Oncology Group Thirteen10 Phase Two Randomized Clinical Trial.